Merck Kgaa (MKGAF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MKGAF | TAK | NBIX | ||
| Company | Merck Kgaa | Takeda Pharmaceutical Ltd ADR | Neurocrine Bioscienc | ||
| Price Information | |||||
| Exchange | OTC US | NYSE | NASDAQ | ||
| Open | 161.8160 | 13.34 | 140.90 | ||
| High | 165.9730 | 13.41 | 141.88 | ||
| Low | 161.8160 | 13.30 | 139.23 | ||
| Last | 162.2300 | 13.37 | 140.71 | ||
| Change | +0.2300 | +0.10 | +0.88 | ||
| % Change | +0.14% | +0.75% | +0.63% | ||
| Volume | 100 | 1,333,900 | 616,500 | ||
| 20-Day Average Volume | 210 | 1,625,240 | 803,360 | ||
| Previous Close | 162.0000 | 13.27 | 139.83 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 161.0891 | 13.30 | 136.80 | ||
| 20-Day Raw Stochastic | 62.84% | 47.40% | 70.11% | ||
| 20-Day Relative Strength | 48.49% | 44.05% | 54.80% | ||
| Weighted Alpha | -9.20 | -20.15 | +45.16 | ||
| Today's Opinion | 40% Sell | 88% Sell | 88% Buy | ||
| Previous Opinion | 40% Sell | 100% Sell | 88% Buy | ||
| Last Month's Opinion | 72% Buy | 88% Sell | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.28% since 04/26/24 | +2.61% since 04/26/24 | +3.47% since 04/26/24 | ||
| Low | 154.1050 on 05/01/24 | 13.08 on 05/01/24 | 136.01 on 05/01/24 | ||
| High | 165.9730 on 05/03/24 | 13.41 on 05/03/24 | 145.22 on 05/01/24 | ||
| 1-Month | |||||
| %Chg | -5.41% since 04/03/24 | -1.18% since 04/03/24 | +2.27% since 04/03/24 | ||
| Low | 152.0500 on 04/22/24 | 13.01 on 04/26/24 | 130.13 on 04/19/24 | ||
| High | 170.6000 on 04/04/24 | 13.77 on 04/08/24 | 145.22 on 05/01/24 | ||
| 3-Month | |||||
| %Chg | +0.77% since 02/02/24 | -6.37% since 02/02/24 | -0.73% since 02/02/24 | ||
| Low | 152.0500 on 04/22/24 | 13.01 on 04/26/24 | 128.00 on 02/07/24 | ||
| High | 180.6800 on 03/22/24 | 14.88 on 02/27/24 | 148.37 on 03/21/24 | ||
| 6-Month | |||||
| %Chg | +0.34% since 11/03/23 | -4.57% since 11/03/23 | +25.14% since 11/03/23 | ||
| Low | 144.7250 on 12/13/23 | 13.01 on 04/26/24 | 103.63 on 11/10/23 | ||
| High | 181.5450 on 11/21/23 | 15.07 on 01/12/24 | 148.37 on 03/21/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 20,937,204 | 41,997,384 | 13,914,065 | ||
| Shares Outstanding, K | 129,242 | 3,164,837 | 99,507 | ||
| Annual Sales | 22,720,720,000 | 29,803,340,000 | 1,887,100,000 | ||
| Annual Net Income | 3,056,420,000 | 2,345,930,000 | 249,700,000 | ||
| Last Quarter Sales | 5,627,630,000 | 7,556,070,000 | 515,200,000 | ||
| Last Quarter Net Income | 632,200,000 | 718,900,000 | 147,700,000 | ||
| 60-Month Beta | 0.97 | 0.56 | 0.28 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.99 on 03/07/24 | 0.51 on 02/01/24 | 1.20 on 05/01/24 | ||
| Latest Earnings Date | 05/08/24 | 05/09/24 | 05/01/24 | ||
| Most Recent Dividend | N/A | 0.261 on 09/28/23 | N/A | ||
| Next Ex-Dividends Date | N/A | 09/28/23 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 18.79 | 6.76 | 39.40 | ||